CN1883642A - Medicine for treating mammary glands hyperplasia - Google Patents

Medicine for treating mammary glands hyperplasia Download PDF

Info

Publication number
CN1883642A
CN1883642A CN 200610081241 CN200610081241A CN1883642A CN 1883642 A CN1883642 A CN 1883642A CN 200610081241 CN200610081241 CN 200610081241 CN 200610081241 A CN200610081241 A CN 200610081241A CN 1883642 A CN1883642 A CN 1883642A
Authority
CN
China
Prior art keywords
radix
medicine
root
weight ratio
chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200610081241
Other languages
Chinese (zh)
Other versions
CN100381155C (en
Inventor
雷秋模
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100812419A priority Critical patent/CN100381155C/en
Publication of CN1883642A publication Critical patent/CN1883642A/en
Application granted granted Critical
Publication of CN100381155C publication Critical patent/CN100381155C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament for treating mammary gland proliferation, which is prepared from Chinese medicinal herbs including (by weight ratio) bupleurum root 5-15, radix salvia miltiorrhiza 8-16, Chinese angelica root 10-20, root of herbaceous peony 10-20, astragalus root 25-35, coix seed 25-35, root of balloonflower 8-12, bitter orange 8-12, green tangerine orange peel 8-12, snakegourd fruit 10-20 parts, seaweed 10-20, nutgrass flatsedge rhizome 8-12 and rhizoma corydalis 10-20.

Description

A kind of medicine that is used for the treatment of cyclomastopathy
Technical field
The present invention is a kind of medicine that is used for the treatment of cyclomastopathy, belongs to the field of Chinese medicines.
Background technology
Mastopathy also has many benign breast diseases except the breast carcinoma of serious harm WomanHealth and life.Wherein, the highest with the cyclomastopathy sickness rate especially, the traditional Chinese medical science should disease the category of ownership " nodules of the breast disease ".Adult women's sickness rate is 57.8%~62.6% more than 30 years old.The possibility of canceration is very easily obscured and had to some type and breast carcinoma.Therefore, research cyclomastopathy class disease has considerable clinical meaning.The attitude of Chinese scholars treatment lays particular stress on and is: when think lump have breast carcinoma may or when dangerous, the excision of just performing an operation; General slight hypertrophy disease, mastalgia are observed.When the violent lump of mastalgia is obvious, then use iodine preparation, lactotropin, progesterone, adrenotrophin, Testosterone, vitamin B6, treatment such as vitamin E, promethazine is observed.
Though above Drug therapy can alleviate some symptoms, be difficult to reach the purpose of healing.Especially adverse consequences also may take place in gonadotherapy.Though China's tradition tcm prescription such as XIAOYAO POWDER or Danzhi Xiaoyao San etc. are effective in cure, also unsatisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of effective Chinese medicine of cyclomastopathy that is used for the treatment of.
From the traditional Chinese medical science " nodules of the breast disease " pathogeny, three of the cause of disease of cyclomastopathy is that irritability is not dredged, and then dysfunction of the spleen in transportation of a specified duration causes stagnation of QI expectorant knot, and newborn network stasis of blood resistance forms.Therapeutic Method is worked as with soothing liver and strengthening spleen, and activating QI to eliminate phlegm, activating collaterals to relieve pain are main.
We are principal agent with the Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI; And active, the Radix Astragali, Semen Coicis invigorating spleen to remove dampness are auxilliary with Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver; Nurse one's health mechanism of qi in the heart with Fructus Aurantii, Radix Platycodonis, Pericarpium Citri Reticulatae Viride, Fructus Trichosanthis, Sargassum resolving phlegm and softening hard masses eliminating stagnation, Rhizoma Cyperi, corydalis tuber promoting the circulation of QI to relieve pain are the assistant treatment.All medicines share, and then the thin spleen of liver is strong, and mechanism of qi is unobstructed, and the expectorant heavily fortified point is soft, and the ruton knot looses and swells and ache from disappearing.
Technical solution of the present invention is: it is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5-15, Radix Salviae Miltiorrhizae 8-16, Radix Angelicae Sinensis 10-20, Radix Paeoniae Alba 10-20, Radix Astragali 25-35, Semen Coicis 25-35, Radix Platycodonis 8-12, Fructus Aurantii 8-12, Pericarpium Citri Reticulatae Viride 8-12, Fructus Trichosanthis 10-20, Sargassum 10-20, Rhizoma Cyperi 8-12, corydalis tuber 10-20.
The weight ratio that said medicine is formed is preferably: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, corydalis tuber 15.
Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
This medicine patient over several years generally reflects well, and curative effect can increase listing Chinese patent medicine such as peaceful with RUKANG PIAN, breast and compare favourably.So far, treatment cyclomastopathy accumulative total has 3123 routine patients.Through clinical observation, prove that the present invention has original curative effect to all kinds of cyclomastopathies.Now from can estimate 567 routine cases, curative effect is summed up and is seen the following form:
The clinical efficacy summary sheet of breast peaceful (No. 3) treatment cyclomastopathy
The medicine name Case load Cure Produce effects Effectively Invalid Effective percentage
Peaceful No. 3 of breast 567 146 193 178 50 91.18%
The specific embodiment
Embodiment 1
The weight ratio that medicine is formed is: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, corydalis tuber 15.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 2
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5, Radix Salviae Miltiorrhizae 8, Radix Angelicae Sinensis 20, the Radix Paeoniae Alba 20, the Radix Astragali 25, Semen Coicis 25, Radix Platycodonis 12, Fructus Aurantii 12, Pericarpium Citri Reticulatae Viride 12, Fructus Trichosanthis 10, Sargassum 20, Rhizoma Cyperi 12, corydalis tuber 10.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 3
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 8, Radix Salviae Miltiorrhizae 10, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 13, the Radix Astragali 25, Semen Coicis 35, Radix Platycodonis 8, Fructus Aurantii 12, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 16, Sargassum 16, Rhizoma Cyperi 12, corydalis tuber 20.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 4
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 18, the Radix Paeoniae Alba 17, the Radix Astragali 30, Semen Coicis 32, Radix Platycodonis 9, Fructus Aurantii 11, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 11, Sargassum 17, Rhizoma Cyperi 9, corydalis tuber 16.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.
Embodiment 5
It is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 7, Radix Salviae Miltiorrhizae 11, Radix Angelicae Sinensis 16, the Radix Paeoniae Alba 13, the Radix Astragali 27, Semen Coicis 31, Radix Platycodonis 11, Fructus Aurantii 11, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 19, Sargassum 13, Rhizoma Cyperi 10, corydalis tuber 18.Choose Chinese crude drug by the said medicine composition, screening is cleaned, and decocts, and reduced-pressure backflow concentrates, and spray granulation is packed the Chinese medicine granules of making at last.

Claims (2)

1, a kind of medicine that is used for the treatment of cyclomastopathy is characterized in that: it is to be made by the Chinese medicine of following weight ratio: Radix Bupleuri 5-15, Radix Salviae Miltiorrhizae 8-16, Radix Angelicae Sinensis 10-20, Radix Paeoniae Alba 10-20, Radix Astragali 25-35, Semen Coicis 25-35, Radix Platycodonis 8-12, Fructus Aurantii 8-12, Pericarpium Citri Reticulatae Viride 8-12, Fructus Trichosanthis 10-20, Sargassum 10-20, Rhizoma Cyperi 8-12, corydalis tuber 10-20.
2, the medicine that is used for the treatment of cyclomastopathy according to claim 1 is characterized in that: the weight ratio that said medicine is formed is preferably: Radix Bupleuri 10, Radix Salviae Miltiorrhizae 12, Radix Angelicae Sinensis 15, the Radix Paeoniae Alba 15, the Radix Astragali 30, Semen Coicis 30, Radix Platycodonis 10, Fructus Aurantii 10, Pericarpium Citri Reticulatae Viride 10, Fructus Trichosanthis 15, Sargassum 15, Rhizoma Cyperi 10, corydalis tuber 15.
CNB2006100812419A 2006-05-26 2006-05-26 Medicine for treating mammary glands hyperplasia Expired - Fee Related CN100381155C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100812419A CN100381155C (en) 2006-05-26 2006-05-26 Medicine for treating mammary glands hyperplasia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100812419A CN100381155C (en) 2006-05-26 2006-05-26 Medicine for treating mammary glands hyperplasia

Publications (2)

Publication Number Publication Date
CN1883642A true CN1883642A (en) 2006-12-27
CN100381155C CN100381155C (en) 2008-04-16

Family

ID=37582025

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100812419A Expired - Fee Related CN100381155C (en) 2006-05-26 2006-05-26 Medicine for treating mammary glands hyperplasia

Country Status (1)

Country Link
CN (1) CN100381155C (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600432A (en) * 2011-10-18 2012-07-25 宋协勘 Traditional Chinese medicine for treating hyperplasia of mammary glands
CN102716296A (en) * 2012-06-24 2012-10-10 李延玲 Breast nodule pill
CN104147507A (en) * 2014-07-16 2014-11-19 桂林医学院附属医院 Oral liquid for eliminating addiction and preparation method thereof
CN112370518A (en) * 2020-11-30 2021-02-19 江西藤康药业有限公司 Medicine for treating hyperplasia of mammary glands and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1175890C (en) * 2002-11-29 2004-11-17 林俊森 Mastoproliferation treating medicine

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600432A (en) * 2011-10-18 2012-07-25 宋协勘 Traditional Chinese medicine for treating hyperplasia of mammary glands
CN102600432B (en) * 2011-10-18 2014-03-05 宋协勘 Traditional Chinese medicine for treating hyperplasia of mammary glands
CN102716296A (en) * 2012-06-24 2012-10-10 李延玲 Breast nodule pill
CN104147507A (en) * 2014-07-16 2014-11-19 桂林医学院附属医院 Oral liquid for eliminating addiction and preparation method thereof
CN112370518A (en) * 2020-11-30 2021-02-19 江西藤康药业有限公司 Medicine for treating hyperplasia of mammary glands and preparation method thereof

Also Published As

Publication number Publication date
CN100381155C (en) 2008-04-16

Similar Documents

Publication Publication Date Title
CN102940853B (en) Navel paste for treating mammary gland hyperplasia diseases
CN103432534B (en) Traditional Chinese prescription for treating hyperplasia of mammary glands
CN103041336B (en) Traditional Chinese medicine composition for treating coronary heart disease
CN102266488B (en) Medicament for treating leucoderma
CN100381155C (en) Medicine for treating mammary glands hyperplasia
CN101721537A (en) Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis
CN103585591A (en) Traditional Chinese medicine for treating gallstones
CN101214365B (en) Chinese medicine composing prescription for treating mastoproliferation
CN101564484B (en) Chinese traditional medicine combination for treating mastosis and preparing method
CN103211886A (en) Medicament for treating rheumatic arthritis
CN103845620A (en) Traditional Chinese medicine for treating raynaud disease
CN100374133C (en) Medicine for treating mammary gland hyperplasia
CN100389815C (en) Medicine for treating mammary glands hyperplasia
CN102078432A (en) Medicament for treating skin itch
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1263479C (en) Chinese traditional medicine for treating cardiopathy
CN101085303A (en) Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN104258272A (en) Traditional Chinese medicine for treating nodules of breast
CN102357193A (en) Traditional Chinese medicament for curing mammary hyperplasia
CN101983712A (en) Novel medicament for treating coronary heart disease
CN103191369A (en) Chinese medicinal composition for treating mammary gland hyperplasia
CN101658661A (en) Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis
CN101953943A (en) Traditional Chinese medicine for treating chronic aplastic anemia
CN101979073A (en) Medicament for soothing liver and regulating Qi

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080416

Termination date: 20140526